Showing results (51-60 of 588) with videos related to

Sort By:
Pageof 59
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancerDaniel Cho, Sabina Signoretti, Meredith Regan, et al.
Hematology/Oncology Clinics of North America|May 31, 2023
The Role of the Pathologist in Renal Cell Carcinoma ManagementSayed Matar, Nourhan El Ahmar, Yasmin Nabil Laimon, et al.
Cancer|April 30, 2009
Treatment selection for patients with metastatic renal cell carcinomaMichael B Atkins, Toni K Choueiri, Daniel Cho, et al.
The Lancet. Digital Health|July 10, 2024
ChatGPT for digital pathology researchMohamed Omar, Varun Ullanat, Massimo Loda, et al.
Cancer Research|October 8, 2013
Twenty-fifth annual Pezcoller Symposium: Metabolism and tumorigenesisWilliam Kaelin, David Livingston, Massimo Loda, et al.
Cell Cycle (Georgetown, Tex.)|January 15, 2014
De novo fatty acid synthesis at the mitotic exit is required to complete cellular divisionNatalia Scaglia, Svitlana Tyekucheva, Giorgia Zadra, et al.
Surgical Pathology Clinics|January 31, 2025
Deciphering Complexity: The Molecular Landscape of Castration-Resistant Prostate CancerGiuseppe Nicolò Fanelli, Pier Vitale Nuzzo, Filippo Pederzoli, et al.
Scientific Reports|October 11, 2022
Mitochondrial transporter expression patterns distinguish tumor from normal tissue and identify cancer subtypes with different survival and metabolismHartmut Wohlrab, Sabina Signoretti, Lucia E Rameh, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 3, 2009
Identification of CD44v6(+)/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodiesEric L Snyder, Dyane Bailey, Michail Shipitsin, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2011
Prognostic determinants in prostate cancerNeil E Martin, Lorelei A Mucci, Massimo Loda, et al.
Pageof 59